How a Wikipedia for drug discovery is disrupting big pharma
From treatments priced beyond the reach of the poor to a refusal to tackle some of the world's most urgent health threats, critics of “big pharma” have seldom had it so easy. Of the $157 billion spent by the private sector on health research and development (R&D) in 2016, just $505 million was for